IRF5 Inhibitor(Totus Medicines)

N/A

Report date: 2026/05/08 20:02:52
NMEFirst In Class

Base Information

Drug NameIRF5 Inhibitor(Totus Medicines)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionInterferon regulatory factor 5 inhibitors
TargetsInterferon regulatory factor 5
Therapy Area/IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicSjogren's Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTotus Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesTotus Medicines Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLupus Erythematosus, SystemicSjogren's Syndrome +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A